| 2VXR | A:868-1088 | CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN SEROTYPE G BINDING DOMAIN |
| 3AZV | A:858-1076; B:858-1076 | CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN |
| 3AZW | A:858-1076; B:858-1076 | CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN |
| 3FUQ | A:868-1085 | GLYCOSYLATED SV2 AND GANGLIOSIDES AS DUAL RECEPTORS FOR BOTULINUM NEUROTOXIN SEROTYPE F |
| 3MPP | G:867-1087 | BOTULINUM NEUROTOXIN TYPE G RECEPTOR BINDING DOMAIN |
| 3N7J | A:862-1067 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D BINDING DOMAIN |
| 3N7K | A:867-1093; B:867-1093 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE C1 BINDING DOMAIN |
| 3N7L | A:863-1076 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D/C VPI 5993 BINDING DOMAIN |
| 3N7M | A:863-1076 | CRYSTAL STRUCTURE OF W1252A MUTANT OF HCR D/C VPI 5995 |
| 3OGG | A:863-1067 | CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN D |
| 3PME | A:868-1085 | CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN C/D MOSAIC SEROTYPE |
| 3R4S | A:864-1093; B:864-1093 | CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES |
| 3R4U | A:864-1093; B:864-1093 | CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES |
| 3RMX | A:862-1067; B:862-1067; C:862-1067; D:862-1067 | CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT |
| 3RMY | A:862-1067; B:862-1067; C:862-1067; D:862-1067 | CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT |
| 3RSJ | A:866-1085; B:868-1085; C:868-1085; D:866-1085 | STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A |
| 4F83 | A:867-1071 | CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN MOSAIC SEROTYPE C/D WITH A TETRAETHYLENE GLYCOL MOLECULE BOUND ON THE HCN SUB-DOMAIN AND A SULFATE ION AT THE PUTATIVE ACTIVE SITE |
| 4FVV | A:863-1076; B:863-1076 | CRYSTAL STRUCTURE OF HCR/D-SA-GBL1/C |
| 4IQP | A:876-1093 | CRYSTAL STRUCTURE OF HCRA-W1266A |
)
)